| scholarly article | Q13442814 |
| P356 | DOI | 10.1096/FJ.201901366R |
| P698 | PubMed publication ID | 31530011 |
| P50 | author | E Agarwal | Q55319427 |
| Dario C Altieri | Q98158352 | ||
| P2093 | author name string | Yuan Wang | |
| Jagadish C Ghosh | |||
| Jae Ho Seo | |||
| Irene Bertolini | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells | Q24302194 | ||
| Direct regulation of TWIST by HIF-1alpha promotes metastasis | Q24316939 | ||
| Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide | Q24561904 | ||
| Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? | Q26852282 | ||
| Restoration of mitochondria function as a target for cancer therapy | Q26864167 | ||
| HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression | Q27025886 | ||
| PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion | Q27324467 | ||
| Comprehensive molecular characterization of clear cell renal cell carcinoma | Q27852374 | ||
| Mitochondrial tumour suppressors: a genetic and biochemical update | Q28285094 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption | Q28300415 | ||
| Modulation of oxidative stress as an anticancer strategy | Q29615707 | ||
| Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity | Q29616651 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability | Q29618122 | ||
| Mitochondrial control by DRP1 in brain tumor initiating cells | Q30300490 | ||
| Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth | Q30300846 | ||
| Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors | Q30300847 | ||
| Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells | Q30576959 | ||
| Chemotaxis in cancer | Q30578627 | ||
| Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress | Q30581882 | ||
| AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion | Q30806095 | ||
| A neuronal network of mitochondrial dynamics regulates metastasis | Q30833071 | ||
| Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons | Q33919516 | ||
| Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET. | Q34217927 | ||
| Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma | Q34299814 | ||
| Up-regulated isocitrate dehydrogenase 1 suppresses proliferation, migration and invasion in osteosarcoma: in vitro and in vivo | Q35187955 | ||
| PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis | Q35204528 | ||
| Redox regulation of cell migration and adhesion | Q35889032 | ||
| Regulators of mitochondrial dynamics in cancer | Q35929111 | ||
| Oxidative stress inhibits distant metastasis by human melanoma cells | Q36277720 | ||
| The hypoxic tumor microenvironment: A driving force for breast cancer progression | Q36368931 | ||
| Notch signaling mediates hypoxia-induced tumor cell migration and invasion | Q36609130 | ||
| Mitochondrial localization and the persistent migration of epithelial cancer cells | Q36824448 | ||
| The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. | Q37126990 | ||
| The cancer diaspora: Metastasis beyond the seed and soil hypothesis | Q37330159 | ||
| Mitochondrial dynamics regulates migration and invasion of breast cancer cells | Q37548419 | ||
| SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense | Q37612791 | ||
| The role of complex II in disease | Q38061764 | ||
| Tumorigenesis: it takes a village | Q38544200 | ||
| Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7. | Q38820611 | ||
| Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis | Q38944573 | ||
| A mitochondrial switch promotes tumor metastasis. | Q38971261 | ||
| Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice | Q39062488 | ||
| Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells | Q39397584 | ||
| Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling | Q39436885 | ||
| Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase | Q42830565 | ||
| IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity | Q45048187 | ||
| SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth | Q46361797 | ||
| Mitochondria and Cancer. | Q53198693 | ||
| Biological Role and Therapeutic Potential of IDH Mutations in Cancer. | Q55456962 | ||
| Targeting the Pathway in Acute Myeloid Leukemia | Q57462264 | ||
| Mitochondria in cancer metabolism, an organelle whose time has come? | Q88882190 | ||
| Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements | Q89093378 | ||
| Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer | Q91051674 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 13398-13411 | |
| P577 | publication date | 2019-09-17 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1α-regulated pseudohypoxic state | |
| P478 | volume | 33 |
Search more.